share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Apr 29 16:31

Gainers

  • GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings came out today.
  • InnovAge Holding (NASDAQ:INNV) shares increased by 7.25% to $3.99. The market value of their outstanding shares is at $542.2 million.
  • Mustang Bio (NASDAQ:MBIO) shares increased by 5.48% to $0.25. The market value of their outstanding shares is at $2.5 million.
  • Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 5.23% to $0.79. The market value of their outstanding shares is at $38.1 million.
  • Seelos Therapeutics (NASDAQ:SEEL) shares increased by 4.88% to $0.29. The market value of their outstanding shares is at $4.0 million.
  • NewAmsterdam Pharma (NASDAQ:NAMS) shares increased by 4.8% to $22.7. The market value of their outstanding shares is at $2.0 billion.

Losers

  • GlucoTrack (NASDAQ:GCTK) stock declined by 10.7% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $13.3 million.
  • Vaxxinity (NASDAQ:VAXX) stock decreased by 9.44% to $0.14. The company's market cap stands at $18.1 million.
  • Ekso Bionics Holdings (NASDAQ:EKSO) stock fell 5.43% to $1.22. The market value of their outstanding shares is at $21.8 million. As per the press release, Q1 earnings came out today.
  • Cosmos Health (NASDAQ:COSM) shares declined by 5.0% to $0.67. The company's market cap stands at $11.3 million.
  • Inozyme Pharma (NASDAQ:INZY) stock decreased by 4.98% to $4.2. The market value of their outstanding shares is at $259.4 million.
  • Prenetics Global (NASDAQ:PRE) shares fell 4.73% to $4.24. The market value of their outstanding shares is at $51.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment